340B Pulse

NorthArcHealth

340B Pulse is a NorthArc Health podcast powered by PureLogics. Built on nearly two decades of experience developing healthcare systems, data platforms, and compliance-driven environments, this podcast focuses on the real operational side of 340B including claims validation, reporting gaps, manufacturer requirements like ESP and Beacon, and program defensibility. This is not about noise or high-level theory. It’s about operator-level conversations — how 340B programs actually function, where friction shows up, and what it takes to run them effectively in the real world.

  1. 17 hr ago

    Checking the Checker: The Hidden Cost of 340B Rebates | Celeste Fowler

    340B rebate readiness is the operational work of identifying, validating, submitting, and reconciling 340B claims under a rebate-based model, then confirming that the rebate a covered entity is owed is the rebate it actually receives. Celeste Fowler, Executive Director of Pharmacy 340B at Piedmont Healthcare, joins 340B Pulse to explain why that work is far bigger than the "five-hour myth" suggests.Everyone's talking about 340B rebate model litigation and manufacturer policy. Almost nobody's talking about who actually checks whether the rebate check that comes back is correct. On this episode of 340B Pulse, host Muhammad Atif sits down with Celeste Fowler, Executive Director of Pharmacy 340B at Piedmont Healthcare, to get past the policy headlines and into what a rebate-based 340B model actually demands operationally. Celeste has spent her career building this kind of program from the ground up, starting as what she calls a "one-woman show" at a single community hospital and now leading a health-system program across multiple facilities. She explains why the widely repeated "five-hour myth" undersells the real work, why more submitted data doesn't automatically create more transparency, why standardization has to be the fixed recipe underneath every program's unique implementation, where AI genuinely earns its place versus where clinical judgment can't be replaced, and what it takes to "check the checker" on a manufacturer's rebate payment before a covered entity can trust it. Why the "five-hour myth" may actually describe five hours a day, not five hours a month, if rebate readiness is done correctlyWhy data integrity and security, not policy uncertainty, is the operational risk healthcare leaders are missingWhat it actually takes to reconcile pharmacy, revenue-cycle, and EMR data that was never built to talk to each otherWhy standardization is the fixed compliance foundation underneath every covered entity's unique 340B programWhere AI and automation genuinely help in 340B operations, and where human clinical judgment has to stay in the loopWhat "checking the checker" means for a covered entity's cash flow and financial sustainabilityHow to build cross-departmental governance and vendor accountability across a health system 00:00 — Cold open: the real cost of rebate readiness 00:30 — Welcome to 340B Pulse 03:35 — Celeste Fowler's path into 340B leadership 07:34 — What healthcare leaders are missing operationally 12:34 — The five-hour myth, explained 14:16 — Mapping the real data gaps behind every claim 18:02 — Why standardization is the core of a defensible program 20:02 — Where AI and automation actually help 25:45 — Data security, AI vendors, and patient trust 28:35 — Financial sustainability and checking the checker 35:18 — Governance and vendor accountability at health-system scale 37:47 — Rapid fire: what rebate readiness actually takes 41:47 — 340B training, coalitions, and building a support network 45:11 — Celeste's final perspective for healthcare leaders 46:03 — Connect with Celeste Fowler What is the five-hour myth in 340B rebate readiness? It's the idea that preparing for a rebate-based 340B model only takes a few extra hours a month. Celeste says that number really only covers uploading a file, and that doing the work behind it properly could take closer to five hours a day. What does "checking the checker" mean? It means a covered entity has to independently confirm that the rebate a manufacturer pays back actually matches what was owed, instead of just trusting the number that comes in. Why does standardization matter so much for 340B programs? Because it gives every site the same compliance baseline, so when something looks off, a team can actually trace it back to the cause instead of guessing whether it's a real problem or just normal variation. #HealthcareCompliance#PharmacyOperations#AIinHealthcare#HealthcareInnovation#HealthcareDataSecurity

  2. 20 Jul

    The Cash Cow Mistake: What 340B Leaders Get Wrong About Savings | David Dunson

    340B savings don't become mission impact automatically. Someone has to decide where the money goes, defend that decision to a board, and be ready to prove it to a regulator. This episode shows exactly what that looks like in practice.In this episode, Mohammad Atif sits down with David Dunson, in-house pharmacist and 340B program leader at Tug River Health Association, a six-clinic rural health center with one mobile unit serving McDowell County, West Virginia, the poorest county in the state and among the poorest in the country. David walks through the real allocation calls behind Tug River's 340B program: choosing to fund a dormant dental program over whole-facility backup generators after Hurricane Helene, rebudgeting a full year ahead of the Medicare Part D rebate program's impact on net savings, and running a monthly cross-departmental 340B committee that keeps every department's priorities visible to the board.He also delivers a candid, occasionally blunt take on where the industry gets 340B wrong: the "cash cow" mentality that leaves organizations blindsided when savings drop, why documentation has to be audit-ready at all times rather than assembled after the fact, and an optimistic but grounded view of where AI actually fits into 340B operations today.00:00 - Introduction to 340B Pulse and the Cold-Open Hook Reel 00:39 - What Happens to 340B Savings After They Arrive? 01:31 - Meet the Host: Why 340B Pulse Exists 03:04 - Introducing David Dunson and Tug River Health Association 03:34 - From Board Member to In-House Pharmacy Owner: David's 25-Year Path 05:19 - Inside Tug River: Six Clinics, One Mobile Unit, McDowell County 06:34 - Defining Mission Impact: Every Patient Gets Care 08:30 - Getting Departments Aligned Around a Shared Mission 09:56 - Reviving a Dormant Dental Program With 340B Savings 11:53 - Competing Priorities: Generators vs. Dental Care After Hurricane Helene 13:54 - Leading Under Uncertainty: The Medicare Part D Rebate Program 16:31 - The $1,100-to-$2,000 Reality of Serving Tug River's Patients 17:23 - Why 340B Should Never Be Treated Like a Cash Cow 18:05 - Governance: Presenting Best-Case and Worst-Case Scenarios to the Board 18:53 - Documentation, HRSA's Patient Definition, and Audit Readiness 23:04 - The Real Cost of Managing a 340B Program 24:43 - Manufacturer Reporting and Working With a TPA 28:15 - Where AI Fits Into 340B Operations 29:58 - Patient Privacy Concerns and Building Trust in AI 31:40 - Preparing the Board for the 340B Coalition Conference 32:53 - Rapid Fire Round With David Dunson 34:32 - Final Perspective: Mission Impact vs. Growth for Growth's Sake 36:03 - How to Connect With David Dunson 36:44 - Closing ThoughtsWhat is 340B mission impact? 340B mission impact is the result of a covered entity's leadership making intentional, documented, and defensible decisions about how 340B savings are allocated, so that the savings translate into measurable patient outcomes rather than simply being absorbed into general operations.What is the biggest mistake covered entities make when planning 340B allocations?The biggest mistake is treating 340B like a permanent cash cow, budgeting as if net savings will remain stable indefinitely, which leaves an organization unprepared and financially exposed the moment a policy change or reduction in savings actually happens.What does strong 340B governance look like, according to David Dunson? According to David Dunson, strong 340B governance means running a standing cross-departmental committee that meets monthly, and presenting a board with multiple scenarios, what leadership expects, what it hopes happens, and what might happen instead, rather than a single optimistic projection.#340BMissionImpact #340BPulse #NorthArcHealth #340BProgram #RuralHealthcare #HealthcareCompliance #CommunityHealthCenters #PharmacyOperations #CoveredEntity #AIinHealthcare

  3. 13 Jul

    Zero Discount, Half the Diabetes Rate: The 340B Blind Spot in Rural Kentucky | Ronnah Alexander

    A rural 340B program is a network of independent contract pharmacies functioning as an extension of the care team, not a single in-house pharmacy counter. Ronnah Alexander, BSPharm, MBA, ACE, who leads the 340B program at Health First Community Health Center in western Kentucky, explains how that model actually runs day to day, and how a device that gets zero 340B discount became one of the highest-impact uses of program savings her clinic has made. In this episode, Ronnah who's spent 36 years in pharmacy and nearly a decade specifically in 340B walks host Muhammad Atif through what it actually takes to run a rural 340B program: treating contract pharmacies as a real extension of the care team, absorbing growing manufacturer reporting requirements without losing focus on patients, and funding a continuous glucose monitor program entirely out of program savings even though the device itself gets no 340B discount at all. That program helped cut her clinic's uncontrolled diabetic rate from 33 percent to 19 percent in two years. She's candid about where the program is straining, too: a shrinking charity-care ceiling, the confusion left behind when the 340B rebate model paused, and which patients still fall through the cracks even when the program works exactly as designed. She closes with a direct message for policymakers not a request for more money, but a request for a single, coordinated plan. Why rural 340B programs depend on independent contract pharmacies instead of in-house pharmacies How a contract pharmacy helped an incarcerated patient complete his Hepatitis C treatment Why keeping a drug's price down can actually push its own 340B price up How a device that gets zero 340B discount cut uncontrolled diabetes nearly in half Which patients are most likely to fall through the cracks even with 340B in place What Ronnah wants policymakers to understand about rural 340B before the next round of restrictions lands 00:00 Introduction to 340B Pulse 00:33 Ronnah Alexander's journey into 340B 06:04 What 340B actually looks like in rural Kentucky 09:08 Contract pharmacies as an extension of the care team 11:32 Handling growing manufacturer compliance requirements 13:31 The 340B rebate model: relief and new confusion 17:29 Patient impact: insulin and chronic disease access 20:43 The CGM program and cutting uncontrolled diabetes in half 25:57 Manufacturer restrictions from the inside 27:51 Transparency, ESP, and duplicate-discount avoidance 29:39 Preparing for the future of 340B 32:15 Ronnah's advice to policymakers 33:20 Rapid fire round 34:22 Closing and how to connect with Ronnah Why do rural 340B covered entities rely on contract pharmacies?  Because most rural clinic locations don't have enough patient volume to justify the cost of an in-house pharmacy, pharmacist, and technician, so covered entities partner with locally owned independent pharmacies instead. Does a continuous glucose monitor qualify for a 340B discount?  No a CGM is a device, not a drug, so it receives no 340B discount. Some covered entities fund patient access to CGMs directly out of 340B program savings instead. What does Ronnah Alexander want policymakers to understand about rural 340B?  That covered entities need one single, coordinated blueprint for how the program should run, instead of a continuous stream of individual manufacturer and policy changes that leave them reacting one at a time with no ability to plan ahead.

  4. 6 Jul

    From Losing a Patient to Building a 340B Clinic in an RV | Jordana Latozas

    340B enrollment is the formal process by which an eligible healthcare provider registers with HRSA's OPAIS system to access discounted outpatient drug pricing, and it is far less straightforward than it sounds once patient eligibility and vendor coordination enter the picture.  340B eligibility sounds simple until you actually try to act on it. There's no clear HRSA definition of who qualifies, no standardized compliance checklist, and no guarantee that go-live happens on the timeline your vendor promises. In this episode of 340B Pulse, Mohammad Atif talks with Jordana Latozas, a nurse practitioner in Michigan and founder of Recovery Mobile Clinic, a nonprofit that brings addiction treatment directly to homeless encampments, shelters, and transitional housing. Jordana explains why she built her clinic inside an RV after losing a 23-year-old patient to an opiate overdose, how a Ryan White Part C grant became her doorway into 340B, and why hiring a compliance consultant before go-live was the best decision of her rollout. She also shares her honest, occasionally contrarian views on where AI actually belongs in 340B compliance work and why she considers the now-halted rebate pilot program a delay tactic that would have wrecked her organization's cash flow. What You'll Learn in This Episode: Why HRSA never clearly defines 340B patient eligibility, and the documentation workaround Jordana built instead.The real test for choosing a TPA or wholesaler: response time and communication, not the sales pitch.Why the covered entity is always accountable for a vendor's compliance mistakes.Jordana's honest take on AI in 340B operations, and why over-reliance on it is still a risk.Why the rebate pilot program would have forced a paper-thin-margin nonprofit to front drug costs for months.Interactive Timestamps:  (00:00) - Introduction to 340B Pulse (03:06) - Jordana's Journey and the Founding of Recovery Mobile Clinic (04:55) - How a Ryan White Grant Led to 340B Eligibility (06:54) - Why 340B Patient Eligibility Has No Clear Definition (09:16) - Registration, OPAIS, and Hiring a Consultant (10:54) - The Five Moving Pieces Between Enrollment and Go-Live (12:17) - Building a Compliance Foundation From Day One (13:50) - How to Evaluate a TPA or Vendor Partner (18:11) - Staying Compliant With No Standard Checklist (20:04) - Where AI Actually Fits in 340B Operations (24:36) - Rapid Fire Segment (25:51) - Why the Rebate Pilot Program Was a Delay Tactic (29:23) - Closing Advice for New Covered Entities What is 340B patient eligibility, and why is it hard to define?  340B patient eligibility is the criteria a covered entity uses to determine which patients qualify for discounted drug pricing, and it's hard to define because HRSA gives no direct compliance guidance, leaving each entity to build and defend its own documentation. What is the biggest mistake new 340B covered entities make when choosing a vendor?  The biggest mistake is choosing a TPA or wholesaler based on their pitch instead of their responsiveness, since slow communication during go-live creates delays a new program can't absorb. What is the 340B rebate pilot program, according to Jordana Latozas?  It was a delay tactic that would have required covered entities to front the full cost of drugs and wait months for reimbursement, adding burden without changing who actually benefits from the savings. Learn more about NorthArc Health's custom Agentic AI solutions for 340B compliance: https://www.northarchealth.com

  5. 29 Jun

    Bridging the Gap: How Pharmacy Leadership Drives Health Equity | Darra M. Edwards

    Pharmacy leadership health equity is the operational practice of designing pharmacy strategy and workflows so patients can access, afford, understand, and continue prescribed care, especially during hospital discharge and ambulatory transitions. Darra M. Edwards describes this as embedding pharmacists in medication reconciliation, Meds-to-Beds, chronic disease management, and community partnerships while measuring success through clinical outcomes rather than activity alone. In safety-net systems, 340B savings often fund the sustainable programs that make equitable medication access possible. 340B Pulse is a NorthArc Health podcast powered by PureLogics, featuring operator-level conversations about how pharmacy, 340B, and care delivery work in practice. In this episode, host Muhammad Atif is joined by Darra M. Edwards, PharmD, MSOL-HCM, BCCCP, BCPS, ACE, Corporate Pharmacy Director overseeing 340B programs across a large health system. Darra shares the personal experience that shaped her career: a preventable post-discharge medication gap that inspired her to build a Meds-to-Beds program and champion pharmacy as a strategic driver of health equity. You'll hear how pharmacy leaders operationalize health equity, why 20% to 47% of hospital readmissions are linked to medication access, and why organizations should measure meaningful clinical and biometric outcomes instead of activity alone. Darra also explains how community partnerships improve continuity of care, where healthcare systems unintentionally create friction for patients, how cultural humility strengthens trust, where AI can support transitions of care while human judgment remains essential, and how 340B reinvestment converts program savings into lasting community impact. Timestamps 00:00 Welcome and episode framing: pharmacy leadership drives health equity 02:38 340B as the foundation for medication access and community programs 03:28 Guest introduction: Darra M. Edwards 04:00 Career journey and leadership path 04:18 The Meds-to-Beds origin story 06:53 Pharmacy-led health equity in practice 07:03 Defining health equity 08:08 Embedding pharmacists in care transitions 08:34 Medication access and readmissions 09:23 Care plan gaps and patient trust 12:26 Medication access as a health equity issue 14:28 Reducing avoidable returns after discharge 17:47 Measuring clinical and biometric outcomes 21:49 Building effective community partnerships 25:34 Eliminating patient friction 29:18 Cultural humility and inclusion 32:35 AI and human judgment in care transitions 36:26 Privacy, security, and policy guardrails 39:44 Rapid-fire segment 43:56 Practical first steps and 340B reinvestment 46:48 Closing remarks Q. What is pharmacy leadership health equity? Pharmacy leadership health equity embeds equitable medication access, transitions of care, outcomes measurement, and community partnerships into health system strategy instead of relying on reactive programs after post-discharge failures occur. Q. Why is Meds-to-Beds a health equity priority? Meds-to-Beds places prescribed medications in patients' hands before discharge, reducing retail delays and access barriers that contribute to preventable readmissions and adverse events. Q. How does 340B support pharmacy-led equity work? 340B helps safety-net providers stretch limited resources by funding medication access programs, discharge support, community outreach, and chronic disease services that reimbursement alone often cannot sustain, connecting savings to measurable patient and community impact. #340B #HealthEquity #PharmacyLeadership #MedsToBeds #TransitionsOfCare #MedicationAccess #MedicationReconciliation #Readmissions #CoveredEntity

  6. 21 Jun

    Aging by Design: Protecting Your Family from Cognitive Crises | Duanni Hurd

    In this episode of 340B Pulse, Duanni Hurd, founder of Starlight Caregivers, breaks down how organizations can integrate high-tech systems thinking to empower caregivers and drastically improve long-term aging outcomes. Care team continuous improvement is the ongoing, systematic effort to enhance the delivery and coordination of patient care by shifting from reactive crisis-management to proactive, data-informed strategies. For most families, aging care begins with a sudden emergency a severe fall or an unexpected cognitive decline. Suddenly, you are thrust into a complex medical system, forced to make life-altering decisions. But deploying caregivers isn't the same as truly coordinating care. When organizations simply check off tasks without analyzing the underlying health data, they leave families vulnerable to the next inevitable crisis. If you are a care operator, a family member navigating aging services, or a healthcare innovator, this episode is an essential guide to transforming how we support our aging population. 00:00 - Introduction to 340B Pulse and Guest Duanni Hurd 04:22 - From Tech Infrastructure to the Care Economy 07:34 - Why Care Teams Get Stuck in Crisis-Response Mode 10:31 - The Critical Importance of Early Data Baselines 15:10 - Empowering Caregivers Without Micromanagement 19:42 - Measuring Performance in Highly Emotional Work 28:00 - The Five Systems of Aging by Design 32:12 - How Wearables and Robotics are Changing Care 35:00 - The Dangerous Threat of AI Hallucinations in Healthcare 37:00 - Rapid Fire Questions on Care Team Culture Q - What is Aging by Design? Aging by Design is a strategic framework that ensures successful longevity by proactively managing five core systems: medical, infrastructural, financial, legal, and social support, guaranteeing that extended lifespans are matched with high quality of life. Q - How does care coordination differ from task completion?Care coordination involves analyzing health data, communicating changes to the extended medical team, and adjusting long-term strategies to prevent future crises, whereas task completion is merely executing a checklist of daily chores. Q - What are the risks of AI in aging care?AI models are prone to hallucination fabricating facts or instructions. For an aging adult with dementia or cognitive decline, an AI hallucination is a critical safety hazard, which is why human caregivers remain essential. #CareTeamContinuousImprovement #AgingByDesign #HomeCare #HealthcareTechnology #AIinHealthcare #340BPulse #NorthArc #CareCoordination #HealthcareLeadership #ElderCare

  7. 16 Jun

    Rebate Pilot Blocked: Legal Limits in 340B's Next Phase | Greg Doggett

    If duplicate discounts sound like a narrow compliance topic, this episode will reframe the entire 340B program for you. Greg Doggett has spent roughly fifteen years in the 340B policy world, from 340B Health advocacy to Walgreens pharmaceutical pricing work to advising hospitals and grantees at Powers, Pyles, Sutter & Verville. He joins Muhammad Atif to explain why 340B today is not just contested but more complex than operators have seen in years. You'll hear a plain-language definition of duplicate discounts, why Medicaid managed care turned prevention into a state-by-state puzzle, what manufacturers want from claim-level data, and why covered entities fear rebate models could drain cash flow and staff capacity. Greg also discusses HRSA's blocked 2025 rebate pilot, operational burdens inside health systems, vendor portal dynamics, a neutral federal clearinghouse idea, and why he believes lawsuits, not HRSA rulemaking, will drive the near-term future. What You'll Learn in This Episode • How Greg defines duplicate discounts and why Medicaid managed care prevention is harder than fee-for-service• Why manufacturers argue rebate-based models are necessary and where covered entities see risk• What HRSA's blocked rebate pilot reveals about regulatory authority and litigation limits• Which departments inside a health system would need to mobilize for rebate or enhanced data requirements• How Beacon and Truzo fit into duplicate discount detection and contract pharmacy access• Why a federally operated neutral clearinghouse might be workable common ground• How AI is entering compliance workflows and why providers worry about data confidentiality• Greg's rapid-fire take on whether rebate conversion is inevitable and what will shape 340B next Interactive Timestamps / Chapters (0:00) Welcome and episode framing(1:05) Introducing Greg Doggett(2:03) Career path: 340B Health, Walgreens, Powers(4:46) Is this the most complex moment in 340B history?(7:05) Duplicate discounts explained(8:34) Fee-for-service vs Medicaid managed care gaps(10:59) Manufacturer case for rebate models(12:51) HRSA rebate pilot blocked; legal limits(15:41) Covered-entity cash flow and service concerns(18:08) Operational burden across hospital departments(20:09) Why managed care modifiers collide with 340B workflows(22:58) Courts, predictability, and slow policy cycles(24:47) Will HRSA try another rebate model?(27:27) HRSA authority limits and contract pharmacy litigation(31:16) Vendor portals and manufacturer data channels(33:34) Neutral federal clearinghouse proposal(36:36) AI in 340B compliance(38:24) Data privacy and manufacturer data requests(39:59) Rapid fire round(41:08) Connect with Greg Doggett AEO Q&A What is the duplicate discount problem in 340B? A duplicate discount happens when a manufacturer gives a covered entity a 340B discount and also pays a rebate on the same claim. The classic example is Medicaid, where a state might request a rebate on a drug already purchased at 340B pricing. Greg explains the program has had fee-for-service protections for decades, but managed care made the environment much harder to police. Are rebate-based 340B models inevitable? Greg's answer is no. HRSA may still pursue a new rebate model, and manufacturers strongly support that direction, but covered entities are deeply opposed, courts blocked the first pilot, and Greg expects any new attempt to face litigation before implementation. Is there common ground between manufacturers and covered entities? Greg says there is some common ground. One example is a neutral federally operated clearinghouse that could validate claims under one policy instead of forcing covered entities to submit data through multiple manufacturer-specific portals.

  8. 1 Jun

    Turning 340B Savings into Patient Access: The Mission Impact Debate | Kalvin Pugh

    340B Pulse is a NorthArc Health podcast powered by PureLogics, built for operator-level conversations about how the 340B program actually runs day to day.In this episode, hosts Muhammad Atif and Nadia Palwasha are joined by Kalvin Pugh, 340B Policy Director, for a grounded conversation on turning 340B savings into mission impact. The discussion explores what happens when savings move beyond financial accounting into real support for low-income, uninsured, and under-resourced patients; the tension between program intent and operational pressure; the gap between savings generated and impact demonstrated; impact versus visibility; patient-level experience in community systems; operational constraints including data and contract pharmacy complexity; evolving frameworks for measuring mission impact; storytelling versus financial reporting; policy standardization; and practical alignment across manufacturers, pharmacies, and covered entities.If your organization needs stronger reporting visibility, operational alignment, and custom agentic automation with compliance guardrails, NorthArc Health helps covered entities modernize 340B operations without losing operator control.0:00:00 Welcome to 340B Pulse and episode framing0:02:20 Co-host intro: 340B savings and patient impact 0:04:10 Guest introduction: Kalvin Pugh0:06:20 Kalvin's journey into 340B and policy0:09:00 Defining "turning savings into mission impact" 0:11:30 Biggest gap: savings generated vs. impact demonstrated 0:14:00 What separates organizations with visible patient impact0:16:30 Impact vs. visibility under manufacturer transparency pressure0:19:30 What patients feel when 340B savings work well 0:22:00 Policy debate vs. patients the program was meant to serve 0:24:30 Challenges translating savings into measurable mission impact 0:27:00 Operational constraints: data, contract pharmacy, reporting 0:29:30 Are mission-impact frameworks mature enough? 0:32:00 Policy intent vs. community-level reality 0:34:30 Patient stories vs. purely financial reporting0:37:00 Policy leaders and standardizing mission impact 0:39:00 Designing a system that connects savings to outcomes 0:39:45 Industry context: AHA pushback on Lilly claims-data policy 0:41:00 Rapid-fire: tracking savings, standardized reporting, future policy 0:43:30 Closing advice: human intent across the 340B ecosystem 0:44:30 How to connect with Kalvin PughWhat is 340B mission impact? 340B mission impact is the measurable patient and community benefit when covered entities use program savings to improve access, continuity of care, and services for vulnerable populations served by safety-net providers.Why is 340B mission impact hard to prove? 340B mission impact is hard to prove because reporting frameworks vary by entity type, data is fragmented across operations, and rising manufacturer transparency requirements add administrative burden that can compete with patient-facing capacity.Is 340B a pricing program or a patient access program? 340B is a federal drug pricing program that covered entities should also treat as a patient access program because its savings are intended to expand care and reduce barriers for underserved populations, not only to improve institutional finances.#340B #340BProgram #PatientAccess #SafetyNet #CoveredEntity #HealthcareCompliance #ContractPharmacy #FQHC #HospitalPharmacy #NorthArcHealth #340BPulse

See All (16)

About

340B Pulse is a NorthArc Health podcast powered by PureLogics. Built on nearly two decades of experience developing healthcare systems, data platforms, and compliance-driven environments, this podcast focuses on the real operational side of 340B including claims validation, reporting gaps, manufacturer requirements like ESP and Beacon, and program defensibility. This is not about noise or high-level theory. It’s about operator-level conversations — how 340B programs actually function, where friction shows up, and what it takes to run them effectively in the real world.

Information

  • Creator
    NorthArcHealth
  • Years Active
    2026
  • Episodes
    16
  • Rating
    Clean
  • Copyright
    © NorthArcHealth
  • Show Website
    340B Pulse

You Might Also Like